AMIC Compared With Microfracture for Focal Articular Cartilage Damage of the Hip

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This is a pilot multi-centre RCT of 40 patients (ages 18-55 years, inclusive) undergoing primary hip arthroscopy with a focal articular cartilage defect of the acetabulum to compare the effect of using autologous matrix-induced chondrogenesis (AMIC) in comparison to microfracture on hip function, health-related quality of life, hip pain, cartilage regeneration, health utility, and any adverse events at 2 years. Follow-up will occur at 6 weeks, 6 months, 12 months, 18 months, and 24 months post-surgery.
Epistemonikos ID: f8ba1b03a6c00e558e32d91e4fe15813507a30dd
First added on: May 13, 2024